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1 Abstract
2 The present paper is based on the lecture that I gave on receiving the Nutrition Society’s 
3 inaugural Gowland Hopkins Award for contributions to Cellular and Molecular Nutrition. It 
4 reviews studies on the adipose tissues – brown and white – conducted by the groups that I have 
5 led since entering nutrition research in 1975. The initial focus was on exploring metabolic factors 
6 that underpin the development of obesity using animal models. This resulted in an interest in 
7 non-shivering thermogenesis with brown adipose tissue being identified as the key effector of 
8 facultative heat production. Brown fat is less thermogenically active in various obese rodents, 
9 and major changes in activity are exhibited in physiological conditions such as lactation and 
10 fasting consistent with a general role for the tissue in nutritional energetics. My interests moved 
11 to white adipose tissue following the cloning of the Ob gene. Our initial contributions in this area 
12 included demonstrating nutritional regulation of Ob gene expression and circulating leptin levels, 
13 as well as a regulatory role for the sympathetic nervous system operating through β3-
14 adrenoceptors. My interests subsequently evolved to a wider concern with the 
15 endocrine/signalling role of adipose tissue. Inflammation is a characteristic of white fat in 
16 obesity with the release of inflammation-related adipokines, and we proposed that hypoxia 
17 underlies this inflammatory state. O2-deprivation was shown to have substantial effects on gene 
18 expression and cellular function in white adipocytes. The hypoxia studies led to the proposition 
19 that O2 should be considered as a critical – essential - macronutrient.      
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20 Background
21 I am greatly honoured to receive the Gowland Hopkins Award from the Nutrition Society, and 
22 indeed to be the first recipient. I never met Sir Frederick Gowland Hopkins OM PRS, who 
23 received the Nobel Prize for Physiology or Medicine in 1929 for the discovery of vitamins, being 
24 born a year after he died. There is, however, a tangential link in that my entry into nutrition from 
25 a basic science background in physiology and biochemistry came through joining the MRC Dunn 
26 Nutritional Laboratory in Cambridge in 1975. The Dunn had been founded in 1927 when 
27 Gowland Hopkins was Dunn Professor of Biochemistry in the University, and the original intent 
28 was that he should be directly involved in the research. In practise, because of extensive other 
29 commitments, including as President of the Royal Society, his primary role with respect to the 
30 Dunn was as an advisor and member of the Management Committee. Gowland Hopkins has, of 
31 course, a close association with the Nutrition Society as one of the principal figures behind its 
32 foundation. 
33 My research over the past 40+ years since entering nutrition has centred on the adipose 
34 tissues – first brown and then white. This began following my initial studies at the Dunn where I 
35 had been recruited by Philip James as a member of the then newly formed Energy Group (Fig. 
36 1). The group had been established in recognition of obesity beginning to emerge as a public 
37 health problem. At the time, the incidence of obesity was considerably less than now - in 1980, 
38 for example, 6% of adult males and 8% of adult females in the UK were classified as obese(1) on 
39 the basis of a body mass index >30, while by 2017 the figure was approximately 30% of all adults 
40 (https://www.worldobesitydata.org/country-profiles/). Obesity is, of course, important 
41 primarily because of the increased risk of several associated diseases, particularly type 2 diabetes, 
42 hypertension, coronary heart disease and certain cancers(2,3).
43 The ethos prevailing when we began in the mid-1970’s was that obesity is the product of 
44 ‘gluttony and sloth’, but our focus was on exploring whether there are important metabolic 
45 factors which underpin the development of the disorder. My remit was to investigate the 
46 fundamentals of the regulation of energy balance using animal models. The animal of choice was 
47 the genetically obese ob/ob (Lepob/Lepob) mouse, and a colony of the Aston strain of these 
48 mutants was set-up. The attraction of ob/ob mice, which at the time were the most widely used 
49 animal model in obesity research, was that not only is the obese state extreme with body weight 
50 being up to three times that of lean siblings but that it is reducible to a mutation in a single 
51 recessively inherited gene(4). The link to a mutant gene meant that the obesity of ob/ob mice 
52 results from a change in just one protein - and that protein must play a critical role in the 
53 regulation of energy balance.
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54 The ob/ob mouse is not, of course, the only rodent in which obesity is the result of a single 
55 gene mutation, and we subsequently established colonies of the other major obese mutants - the 
56 Zucker fa/fa (Leprfa/Leprfa) rat and the diabetic-obese db/db (Leprdb/Leprdb) mouse(4). We were 
57 later able to house colonies of the Adipose mouse (Ad), golden hamsters (Mesocricetus auratus) and 
58 Djungarian hamsters (Phodopus sungorus), each as a specific model within our energy regulation 
59 studies. This was based on the August Krogh Principle that “for a large number of problems 
60 there will be some animal of choice or a few such animals on which it can be most conveniently 
61 studied”(5). As I have noted previously, the ability to maintain multiple colonies of experimental 
62 animals at the Dunn without direct cost to the investigator was remarkable(6).
63
64 Energy balance and thermogenesis
65 Hyperphagia is part of the basis for the obesity of the ob/ob mouse, and indeed that of the other 
66 obese mutants, food intake being greater than in lean siblings(4). However, studies where young 
67 ob/ob mice were either directly pair-fed to the ad libitum intake of their lean siblings, or otherwise 
68 given restricted amounts of food, indicated that obesity still develops without hyperphagia(7,8). 
69 Our own work, in which full energy balance studies were performed, clearly illustrates the point; 
70 young ob/ob mice pair-fed to the ad libitum intake of lean siblings at room temperature (23oC) 
71 exhibited a rate of energy deposition 2.3 times that of the lean(7). The study was conducted at 
72 four different environmental temperatures – 33o (thermoneutral for the mouse), 28o, 23o and 
73 17oC. At each temperature, the energy gain of the obese animals was greater than the lean, but 
74 the lower the temperature the higher the excess gain(7).
75 The capacity for excess energy deposition in the absence of hyperphagia indicated that one 
76 or more components of energy expenditure is reduced in the ob/ob mutants. Of the main 
77 components of expenditure, facultative (or adaptive) non-shivering thermogenesis (NST) was 
78 particularly attractive as the key element. Not only is thermoregulatory thermogenesis a major 
79 part of total expenditure in small mammals in order to maintain body temperature, but reduced 
80 expenditure on thermogenesis was being advocated by Miller and Stock as a causal factor in the 
81 development of obesity(9,10). Furthermore, some 25 years earlier impaired homeothermy had 
82 been noted in ob/ob mice(11). This appeared counter-intuitive given the improved insulation 
83 provided by the additional body fat of the obese animals, and was suggestive of a reduced 
84 capacity to generate heat. In our own studies, core temperature fell rapidly - to as low as 15oC - 
85 just 3 h after exposure of ob/ob mice to 4oC, whereas lean siblings maintained their temperature 
86 above 35oC(12).
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87 Direct measurements of NST from the peak increase in resting metabolic rate at 
88 thermoneutrality following the administration of noradrenaline indicated that the capacity for 
89 this form of heat production was 2-fold lower in ob/ob mice than lean siblings(12). Furthermore, 
90 resting metabolic rate – expressed ‘per animal’, as should be done in energetic studies – was 
91 reduced in the obese mice relative to the lean at every temperature examined below 
92 thermoneutrality, indicating a lower expenditure on NST(12).
93  
94 Brown adipose tissue
95 An immediate question raised by these physiological studies was the nature of the molecular and 
96 cellular mechanisms of NST. Several possibilities were under consideration at the time, including 
97 protein turnover, the α-glycerophosphate shuttle, Na+ transport across the plasma membrane 
98 mediated by Na+-K+ATPase, and futile/substrate cycles such as that between fructose-6-
99 phosphate and fructose-1,6-bisphosphate(13-19); in practise, most are in effect a form of energy-
100 consuming substrate cycle. There were, however, substantial reservations with each of these 
101 mechanisms(20) in that it seemed unlikely that they had the potential to generate sufficient 
102 quantities of heat and to do so acutely without disrupting normal metabolic control. In addition, 
103 there was a central issue of tissue localisation - several of the mechanisms, particularly protein 
104 turnover and Na+ transport, being essentially universal rather than restricted to a specific tissue 
105 site.
106 The question of the tissue basis for NST subsequently centred on brown adipose tissue 
107 (BAT, or brown fat), which had first been described by Conrad Gessner in 1551. Although 
108 different roles had been proposed for this tissue, including as an endocrine organ, the principal 
109 function was resolved in the early 1960s - as a thermogenic organ with heat as the primary 
110 product(21). The tissue is prominent in hibernating species, in the newborn of many mammals 
111 (including humans) and in rodents acclimated to the cold(22,23). The quantitative importance of 
112 BAT in adaptive NST in rodents was demonstrated in influential studies by Foster and 
113 Frydman(24-26). These authors mapped regional blood flow to different tissues using radioactively-
114 labelled microspheres in rats in which NST was maximally stimulated following either cold-
115 acclimation or the administration of noradrenaline. From the measurements of regional blood 
116 flow, together with the cardiac output and the oxygen extraction across the interscapular depot, 
117 BAT was estimated to account for 60% of NST in cold-acclimated rats(25). Our own studies on 
118 mice using the same approach suggested a broadly similar figure(7).
119 In parallel with the identification of BAT as the principal locus for NST, the unique 
120 bioenergetic properties of the tissue’s mitochondria were being elucidated. Heat was shown by 
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121 Nicholls to be generated by a regulated uncoupling of oxidative phosphorylation, the energy 
122 inherent in the proton gradient across the inner mitochondrial membrane being dissipated as 
123 heat rather than coupled to ATP synthesis(22). This process is controlled by the 32,000 Mr 
124 mitochondrial uncoupling protein-1 (UCP1) discovered by Ricquier(22,27). Acute stimulation of 
125 BAT thermogenesis leads to an activation of UCP1, while chronic stimulation results in an 
126 increase in the amount of the protein – through a combination of a higher concentration in the 
127 mitochondria and through mitochondriogenesis(23). These changes, both acute and chronic, are 
128 primarily driven by the release of noradrenaline from the extensive sympathetic innervation of 
129 BAT, acting mainly via β3-adrenoceptors(28,29).
130 My group at the Dunn, in parallel with several other groups, began to explore the potential 
131 role of BAT in energy balance and the development of obesity. Two seminal observations were 
132 pivotal; in the first, Himms-Hagen and Desaultels in Ottawa demonstrated reduced GDP 
133 binding to BAT mitochondria in ob/ob mice relative to lean siblings, this reflecting a reduction in 
134 the thermogenic proton conductance pathway of the tissue(30). Our own blood flow studies 
135 indicated that the reduced NST and consequent lower energy expenditure of the obese mutant is 
136 entirely due to decreased metabolic activity in BAT(31). In the second key study, Rothwell and 
137 Stock in London proposed that BAT is the locus of the diet-induced thermogenesis that they 
138 were observing in rats overfed through the provision of a cafeteria diet(32). In follow-up studies 
139 with our group, key molecular indices of BAT thermogenic activity were demonstrated in the 
140 cafeteria-fed animals – increased mitochondrial mass and GDP binding, as well as GDP-
141 sensitive respiration(33).
142 These initial reports were followed by a series of studies in which the thermogenic activity 
143 of BAT was shown to be reduced in a variety of obese rodents. They included other single gene 
144 mutants – fa/fa rat and db/db mouse – and rodents with experimentally-induced obesity such as 
145 that following lesioning of the ventromedial hypothalamus, the administration of gold 
146 thioglucose, and treatment with corticosteroids(20,34,35). Along with the studies on obese animals, 
147 the role of BAT in nutritional energetics was further explored in a range of physiological and 
148 pathophysiological situations in which body fat and energy flux change (Fig. 2). These included 
149 the reproductive cycle – pregnancy and lactation – hibernation, photoperiod, cancer cachexia and 
150 nutritional manipulations such as fasting/refeeding and the provision of a low protein diet(34,35).
151 Lactation was a physiological stress of particular interest to us at the Dunn. The energy 
152 cost of lactation is high in small mammals, and energy intake is increased by approximately 3-
153 fold in lactating rats, for example, compared to virgin animals(36,37). Our studies in mice showed 
154 that BAT thermogenesis is suppressed in lactation, the suppression being maximal in late 
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155 lactation when milk production peaks(38-40). Mitochondrial mass and GDP binding are both 
156 markedly reduced in BAT of lactating mice, the latter to the same level as virgin animals at 
157 thermoneutrality(38,39). The concentration of UCP1 in the mitochondria is also reduced relative to 
158 that of virgin mice, with the total UCP1 content of the interscapular pad at late lactation being 
159 <10% of the virgin animals (Fig. 3)(39). These changes in BAT activity effectively lead to a 
160 substantial energy saving, helping to meet the high energy cost of milk production. However, this 
161 adaptation essentially reflects the limited scope for heat dissipation in the face of the high 
162 metabolic heat generation associated with milk synthesis rather than a specific energy saving 
163 mechanism as such, as convincingly argued in a recent review on BAT in lactation(40). 
164 Perhaps the strongest illustration of the link between energy expenditure and BAT 
165 thermogenesis comes from the changes in the tissue that occur when small rodents are 
166 acclimated to the cold. In mice, energy expenditure and food intake are increased 3-fold between 
167 thermoneutrality and 4oC, reflecting the energy cost of generating heat for homeothermy(12,41). In 
168 rats acclimated at 4oC, the mitochondrial content, mitochondrial GDP binding and UCP1 
169 concentration were each substantially higher than in rats acclimated to thermoneutrality (29oC), 
170 while the total UCP1 content of the interscapular BAT depot was increased by >100-fold(42). 
171
172 Brown adipose tissue in humans
173 By the beginning of the 1990s, the importance of BAT in nutritional energetics had been firmly 
174 established across a range of obesity models and in other conditions in experimental animals in 
175 which energy flux is altered. In the case of humans, interest in the tissue had been driven to a 
176 considerable extent by the concept that reduced thermogenesis is a key factor in the 
177 development of obesity in humans and that BAT is a potential therapeutic target for the 
178 treatment of the disorder. 
179 Although brown fat was widely recognised to be an important locus of heat production in 
180 the human neonate, the tissue appeared – on the basis of histological appearance – to be absent 
181 after the first few years of life. The presence of BAT in adult humans was confirmed, however, 
182 by immunological studies identifying UCP1 in fat depots, including in some elderly subjects(43-45). 
183 In addition, expression of the UCP1 gene was evident through detection of the encoded 
184 mRNA(46). Activation of the tissue in patients with phaeochromocytoma was also 
185 demonstrated(47,48).
186 Despite the clear evidence for the presence of BAT in adults, with the capacity for 
187 adaptive changes, the prevailing view was that the tissue was of little, or no, significance in 
188 human energetics other than in neonates and during the first years of life. Interest in BAT then 
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189 declined markedly, with the notable exception of those groups (particularly that of Cannon and 
190 Nedergaard in Stockholm(23)) whose principal focus was on understanding the fundamental 
191 biology of the tissue. Since 2009 there has, however, been renewed interest on BAT in humans 
192 following the application of fluorodeoxyglucose positron emission tomography(49-51). This has 
193 firmly demonstrated active BAT in adults, activity being reduced in obesity and with ageing, for 
194 example, while being stimulated on cold exposure and by the administration of a selective β3-
195 adrenoceptor agonist(49-55).
196
197 White adipose tissue – the discovery of leptin
198 As interest in BAT declined, my own research focus changed and abruptly so following the 
199 cloning of the Ob (Lepob) gene and the identification of the encoded protein(56) Within days of the 
200 report in Nature on 1 December 1994, my group at the Rowett in Aberdeen (where I had 
201 relocated in 1988) had designed and validated oligonucleotide probes to examine Ob gene 
202 expression. This move reflected the fact that some two years earlier a consortium of us in the 
203 UK, which included Michael Stock and John Stirling, had sought funding to identify the 
204 defective genes in the obese mouse mutants. We were, however, unsuccessful since it was argued 
205 (correctly) that at least one group in the United States was well-advanced in the goal and that it 
206 was unlikely that we could be competitive. My response was that once the Ob gene had been 
207 identified, our strategy would be to explore the physiology of the protein product. 
208 The Ob gene was reported to be expressed in white adipose tissue (WAT) and the protein 
209 – initially termed ‘OB’, and then leptin – to act as a lipostatic signal(56-58). Subsequently, the 
210 hormone was found to be produced by several tissues, including BAT(59) and the placenta(60), 
211 although WAT is the major source. Similarly, the functions attributed to leptin quickly expanded 
212 and it became regarded as a pleiotropic factor(61). The early studies of my group at the Rowett 
213 demonstrated that expression of the Ob gene is nutritionally regulated, the mRNA level in WAT 
214 of lean rodents rapidly decreasing on fasting with a restoration on refeeding(62). The circulating 
215 levels of the hormone change in parallel with the alterations in gene expression(63).
216 We then showed that acute exposure of mice to cold led to a strong inhibition of Ob 
217 expression, and a fall in circulating leptin level, both of which are rapidly reversed on return to a 
218 warm environment(64,65). The cold-induced reduction in Ob mRNA level was mimicked by the 
219 administration of noradrenaline and by the β-adrenoceptor agonist isoprenaline. From these 
220 observations we proposed that the sympathetic system plays a key role in the regulation Ob gene 
221 expression(64). Subsequent observations indicated that this operates primarily through β3-
222 adrenoceptors(65,66). Further studies on leptin at the Rowett included the demonstration by in situ 
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223 hybridisation that the receptor, and particularly the long form responsible for signalling, is 
224 strongly expressed in regions of the hypothalamus, consistent with being an adipocyte-derived 
225 signal for appetite(67). 
226
227 Adipokines and the secretory function of white adipocytes
228 Leptin quickly became a major area in research on obesity and its associated disorders. One of 
229 the key outcomes of the discovery of the hormone was a radical change in perspective on the 
230 functions of white adipocytes and therefore of WAT itself. Adipocytes were recognised as 
231 endocrine cells with WAT as a major signalling organ(68-71). Although secreted protein factors 
232 had been identified previously, this had not led to the conceptualisation of white adipocytes as 
233 endocrine and signalling cells. The secreted proteins known prior to leptin were adipsin 
234 (complement factor D)(72), which is a serine protease, the cytokine TNFα(73), and lipoprotein 
235 lipase. Lipoprotein lipase is, of course, released from adipocytes to catalyse the breakdown of 
236 circulating triacylglycerols to enable the uptake of fatty acids into adipocytes; it was not, however, 
237 regarded as a fat cell secretory protein as such.
238 The ‘secretome’ of adipocytes, and of WAT as a whole, is extensive (Fig. 4). Quantitatively, 
239 fatty acids are the largest secretory product, but there are several other lipid groups released from 
240 the cells. Some, such as specific prostaglandins and the endocannabinoid anadamide, are 
241 synthesised de novo within adipocytes, while others, including cholesterol and vitamin A, are taken 
242 up, stored, and subsequently released(61). A question raised by the discovery of leptin was 
243 whether there are a range of protein hormones and signals synthesised and secreted by fat cells. 
244 The answer is very much in the affirmative and one of the earliest of these adipokines, as they 
245 are termed, identified was another major adipocyte hormone, adiponectin, whose functions 
246 encompass insulin sensitising, angiogenic and anti-inflammatory actions (Fig. 3)(74-78). 
247 The search for novel adipokines became a core focus of my group, both at the Rowett and 
248 later at the University of Liverpool to where I moved in 2002. Among the several adipokines that 
249 we discovered were: the neurotrophic signal nerve growth factor(79); specific metallothioneins(80), 
250 these having metal binding actions; and the lipolytic/cachetic factor zinc-α2-glycoprotein(81,82). 
251 Nerve growth factor was found to be linked to the inflammatory response in WAT, secretion of 
252 the protein being strongly stimulated by TNFα(79). As in mice, zinc-α2-glycoprotein expression 
253 increased substantially in WAT of patients with cachexia associated with gastrointestinal 
254 cancer(83).
255 An extensive range of individual adipokines has now been identified, and proteomic 
256 studies and in silico analysis suggest that there are several hundred in total(84-86). The wide-ranging 
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257 secretory function of white adipocytes established over the past two decades has in part served 
258 as a model for other cell types which were not previously regarded as having a significant 
259 endocrine or signalling function. Myocytes, for example, are now known to release a range of 
260 proteins signals - myokines(87,88) - while another example is hepatocytes which secrete multiple 
261 hepatokines(89).  
262 The identification of a multiplicity of protein signals and factors from adipocytes indicated 
263 that WAT is involved in a range of physiological and regulatory processes(61,70,90-92). While some 
264 adipokines are endocrine in function, signalling to tissues and organs distant to the adipose 
265 depots, others have local paracrine and/or autocrine actions. The processes in which various 
266 adipokines play a role include appetite and energy balance, lipid metabolism, vascular 
267 haemostasis, blood pressure, angiogenesis and insulin sensitivity (see(61,91)). A number of 
268 adipokines are linked to immunity and inflammation, these including classical cytokines and 
269 chemokines such as IL-1β, IL-6, IL-10, and MCP-1; they also include inflammation-related 
270 factors, examples being VEGF, serum amyloid A and adiponectin (see(61,70,91). 
271 In obesity, WAT exhibits chronic mild inflammation with increased production and release 
272 of inflammatory adipokines. There is a notable exception to this in that the synthesis and release 
273 of adiponectin, with its anti-inflammatory action, falls(93,94). Inflammation in expanded WAT is 
274 augmented by the infiltration and activation of macrophages in particular, but also of other 
275 immune cells(92,95-97). 
276
277 Hypoxia and the metabolic response to oxygen deprivation in adipocytes
278 Inflammation in WAT has been considered a key factor in the development of the major 
279 obesity-associated disorders, particularly insulin resistance and the other components of the 
280 metabolic syndrome(3,70,98,99). The question that intrigued me in the early 2000s was why does 
281 inflammation develop as adipose tissue mass expands? A ‘News’ article in Science on how cells 
282 endure low oxygen(100) encouraged me to consider the possibility that hypoxia might be a key. 
283 This was presented as a hypothesis in a ‘Horizons’ article in the British Journal of Nutrition in 
284 2004(90). I am particularly proud of this paper: not only does it describe the hypoxia hypothesis, 
285 but it is my most highly cited publication (>1,400 citations in the Web of Science; >2,450 
286 citations in Google Scholar) as well as being the fourth most highly cited article in the Nutrition 
287 Society’s flagship journal (or indeed in all of its journals).
288 The hypothesis proposed that as adipose tissue mass expands with the development of 
289 obesity, areas within the tissue become relatively hypoxic as the enlarging adipocytes become 
290 more distant from the vasculature, this leading to major adaptive changes involving the hypoxia-
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291 inducible transcription factor HIF-1. The recruitment of HIF-1 was hypothesised to lead to 
292 increased expression of a series of hypoxia-sensitive genes linked to inflammation and the 
293 inflammatory response in WAT. The proposition was based on the following: (i) hypoxia occurs 
294 in situations such as ischaemic injury, wound healing and solid tumours leading to extensive 
295 metabolic changes(90), (ii) blood flow to WAT is not increased in obese subjects, despite the 
296 higher mass of the tissue(101-104), (iii) in contrast to lean subjects, blood flow to WAT does not 
297 increase post-prandially in the obese(104-106), (iv) large adipocytes (which may be up to 200 μm 
298 diameter(107)) are further from the vasculature than the normal diffusion distance for O2 (100 
299 μm)(108). These observations refer to local hypoxia, but the provision of O2 on a whole-body 
300 level is reduced in specific environmental and pathological situations, such as high altitude, deep 
301 sea dives, lung diseases and obstructive sleep apnoea(61,108). 
302 In 2007, studies using two separate techniques reported that WAT depots in different 
303 types of obese mouse are hypoxic, with the O2 tension being 2- to 3-fold lower than in lean 
304 mice(109,110). Subsequent studies on mice were consistent with these observations(111). In contrast, 
305 although some human studies have indicated that WAT depots are relatively hypoxic(103,112) 
306 others have reported either the same or an increase in pO2 (partial pressure of oxygen)(106,113). 
307 The issue remains unresolved, but there is evidence that differences in the way in which O2 is 
308 delivered in terms of vascularisation and utilisation may occur(106,113,114).
309 From 2004 the focus of my group in Liverpool was on examining the direct effects of 
310 hypoxia on gene expression and cellular function in adipocytes. Almost all of our studies were 
311 conducted on human adipocytes, differentiated in culture from fibroblastic preadipocytes. The 
312 initial priority was to examine whether incubation under a low O2 tension leads to increased 
313 expression and release of inflammation-related adipokines consistent with our initial hypothesis. 
314 A candidate gene approach was employed and increased production of several adipokines was 
315 observed, including IL-6, VEGF and leptin(115). Raised production of VEG and leptin, as well as 
316 of specific matrix metalloproteinases, had been reported earlier in 3T3-F442A adipocytes (a 
317 mouse cell line), reflecting a pro-angiogenic response to hypoxia(116).
318 The key cellular adaptation to O2 deficiency is a switch from aerobic to anaerobic 
319 metabolism. Mitochondrial oxidative phosphorylation cannot, of course, continue when O2 is 
320 severely limited, and there is instead increased anaerobic glycolysis. As expected, adipocytes 
321 exhibit greater glucose uptake under hypoxic conditions, as demonstrated by 2-deoxy-D-glucose 
322 uptake studies(117) and by measurement of glucose in the culture medium(116). This is mediated 
323 through increased synthesis of the GLUT1 facilitative glucose transporter, driven by a marked 
324 stimulation of GLUT1 gene expression(117). The expression of several genes encoding glycolytic 
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325 enzymes is also raised, glucose-6-phosphate isomerase and phosphofructokinase for example(118, 
326 119). Lactate release is augmented in hypoxic adipocytes(116,120), reflecting the increased glucose 
327 utilisation and glycolytic flux, this being mediated by increases in the synthesis of the 
328 monocarboxylate transporter, MCT1(120).   
329 While our initial exploration of the effects of hypoxia on gene expression in human 
330 adipocytes probed selective candidate genes, in subsequent studies more comprehensive 
331 approaches were taken. In the first of these, PCR arrays for 84 genes linked to the hypoxia-
332 signalling pathway were employed. The expression of a number of the genes changed, with one 
333 particular gene exhibiting dramatically increased expression(121). The gene in question was MT3, 
334 which encodes a member of the metallothionein family, metallothionein-3 (also known as 
335 growth inhibitory factor). This protein binds zinc and copper, and linked to its marked induction 
336 by O2-deprivation has been implicated as an angiogenic factor and to protect against hypoxic 
337 damage(122,123).
338 PCR arrays are themselves limited in terms of the number of genes whose expression can 
339 be screened and a specific pathway or metabolic system needs to be selected. DNA microarrays 
340 offer an unbiased approach in which all, or almost all, the genes expressed in a tissue or cell can 
341 be probed simultaneously. Our microarray studies at Liverpool, in collaboration with colleagues 
342 at Unilever, indicated that the expression of >1,300 genes was altered in human adipocytes 
343 cultured under hypoxic conditions, stringent criteria being used to evaluate changes(119). Of these 
344 genes, the expression of approximately half were up-regulated and half down-regulated under 
345 low pO2. Bioinformatic analysis showed that a number of metabolic pathways and functions are 
346 altered in human adipocytes by hypoxia, these including lipolysis, lipid oxidation, glucose 
347 utilisation, cell to cell signalling and cell death(119). 
348 It is evident from these and other studies that hypoxia results in extensive changes in gene 
349 expression in adipocytes. Several important functional changes have been described, in addition 
350 to increased anaerobic glycolysis (Fig. 5). These include the rapid induction of insulin resistance 
351 through the direct inhibition of insulin signalling(124,125), and the disruption of the extracellular 
352 matrix within WAT that characterises fibrosis(126,127). With respect to fibrosis, hypoxia leads to 
353 changes in the expression of collagens released as components of the extracellular matrix, as well 
354 as matrix metalloproteinases(116,126) involved in tissue remodelling. The overall cellular response 
355 to low O2 is regulated by a series of hypoxia-responsive transcription factors of which hypoxia-
356 inducible factor-1 (HIF-1), consisting of two subunits (HIF-1α and HIF-1β), is the best 
357 characterised(108,128,129). 
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358 Our studies, like most that examine the response of cells to hypoxia, were undertaken by 
359 comparing 1% to 20% O2 (95% air/5% CO2 – ‘normoxia’). However, this is an extreme, 
360 effectively representing a comparison between ambient air (higher than arterial pO2) and marked 
361 hypoxia. A questions that interested me was whether there is a critical point at which adaptation 
362 to reduced O2 is initiated in adipocytes, or if there is a gradual response to falling O2 tension. 
363 Experiments in which human adipocytes were incubated with a range of O2 levels between 20% 
364 and 1% clearly demonstrated a ‘dose-dependent’ response to lowering O2 tension with 
365 differences being observed between 21% and 15% and between 15% and 10% O2(130). This was 
366 true for the expression and secretion of several adipokines, including leptin and VEGF, as well 
367 2-deoxy-D-glucose uptake and GLUT1 gene expression. Nevertheless, changes tended to be 
368 more marked between 10% and 5% O2. Since the pO2 in WAT of lean mice is equivalent to 
369 ~7% O2 while in obese mice it is ~2%, it is evident that there are responses to O2-deprivation 
370 over physiologically relevant differences in tissue oxygenation between the phenotypes(91).
371 These experiments on the effects of a range of O2 levels demonstrate that while the 
372 customarily employed protocols in hypoxia studies offer ‘proof of principle’, they lead to an 
373 exaggerated view of the scale of the cellular response to relative O2 lack under normal 
374 physiological conditions. This raises a question of the extent to which our understanding of 
375 cellular processes has been conditioned, or even distorted, by the routine use of 20% O2 as the 
376 gas phase in cell culture and other in vitro experiments. It is intriguing that careful attention is 
377 paid to the pH (7.4), temperature (37oC) and the concentration of glucose and other nutrients in 
378 cell culture to ensure ‘physiological’ conditions (except when they are the parameter under 
379 investigation), but the O2 tension employed is quite unphysiological and indeed reflects overt 
380 hyperoxia.
381
382 Oxygen – an overlooked macronutrient
383 A corollary of our studies on hypoxia is that they underscore that O2 is a key nutrient at the 
384 cellular level. Indeed, investigation of hypoxia is in effect exploration of the molecular and 
385 metabolic consequences of the deficiency of a nutrient. However, O2 is not considered as a 
386 nutrient as such in the context of nutritional science. Textbooks of nutrition do not contain 
387 sections on O2, and reference to it is generally restricted to discussion of metabolic rate and 
388 respiratory quotient. I have argued recently that O2 should be included alongside the other 
389 elements/molecules/macromolecules that are defined as nutrients(131,132). 
390 O2 undoubtedly meets dictionary definitions of a nutrient; for example “as a substance that 
391 provides nourishment for the maintenance of life and for growth” (Oxford English Dictionary). The 
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392 central reason why O2 is not considered as part of nutritional science is because of the route of 
393 entry – the nose/lungs in higher terrestrial animals, rather than the mouth/gastrointestinal tract. 
394 However, I argue that the route of entry should not be the critical determinant of whether O2 is, 
395 or is not, considered a nutrient, but rather its function and essentiality(132). O2 is, of course, 
396 critical to all aerobic species without which mitochondrial oxidative phosphorylation cannot take 
397 place.
398 Early organisms developed under anoxic conditions, the level of O2 in the atmosphere 
399 being just 1 part in a million soon after the Earth was formed some 4.54 billion years ago(133,134). 
400 It was only after the initiation of the ‘Great Oxidation Event’ some 2.45 billion years ago that 
401 considerable amounts of O2 began to appear in the atmosphere(134-136), the present level of 21% 
402 being essentially stable over the past 600 million years(134). The availability of O2 in abundance in 
403 the atmosphere was critical to the evolution of life as we know it.    
404
405 Concluding perspectives
406 An odyssey with the adipose tissues that began for me over 40 years ago has provided much by 
407 way of riches and changed perspectives. The unique bioenergetic properties of BAT 
408 mitochondria, through the presence of the cell-specific UCP1, was initially thought to generate 
409 heat only in relation to temperature regulation. Subsequently, the link to energy balance was 
410 established and the tissue has provided a theoretical target for the treatment of obesity. BAT is 
411 also implicated in metabolic regulation more broadly than was originally envisaged, through roles 
412 in glucose homeostasis and triglyceride clearance(55,137-140). Whether it is a realistic target for the 
413 treatment of obesity and the metabolic syndrome, as many propose(55,137-140), remains a matter of 
414 continuing debate - my own view, as noted recently, is that there are formidable barriers to this 
415 concept(141).
416 Perspectives on the physiological role of WAT have changed radically since the discovery 
417 of leptin. An organ that appeared confined to fuel storage - a view reinforced by the histological 
418 structure with a single lipid droplet taking up most of the volume of mature white adipocytes - 
419 has emerged as having major endocrine and signalling functions. For specific adipose tissue 
420 depots there is good evidence of local impact in relation to the organs and tissues with which 
421 they abut(142); examples are the epicardial fat, postulated to play a role in cardiovascular 
422 disease(143,144), and dermal adipose tissue which is implicated in hair cycling and wound 
423 healing(145,146). A specific role in relation to cancer and tumour microenvironment is also evident 
424 for some depots(147,148). 
425 My research has centred throughout on what are traditionally considered to be BAT and 
426 WAT, both of which are defined by their respective signature cells. However, a third type of 
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427 adipocyte is now recognised, namely the beige or brite cell(149,150). Beige adipocytes have some, 
428 though not all, the characteristics of brown fat cells, and in particular are thermogenic through 
429 the presence of UCP1. Beige adipocytes are found predominantly within what are regarded as 
430 WAT depots and a number of factors lead to their recruitment, particularly cold exposure and β-
431 adrenergic stimulation(151,152). The complexity and diversity of fat cells may be even greater with a 
432 recent study reporting four distinct human adipocyte subtypes(153).
433 Although work on hypoxia has focused on WAT, with substantial changes in gene 
434 expression and function being demonstrated in white adipocytes, a deficiency in O2 availability 
435 can also occur with BAT. BAT has an exceptionally high O2 demand in order to fuel 
436 thermogenesis and hypoxia has been noted in the tissue of normal mice exposed to cold(154). 
437 Hypoxia is not evident, however, in mice acclimated to a warm environment (30oC), and studies 
438 on Ucp1 knockout animals indicate that it occurs only with thermogenesis(154). Obese mice 
439 exhibit vascular rarefaction and a substantial reduction in pO2 in BAT compared with lean mice, 
440 leading to a ‘whitening’ of the tissue together with mitochondrial dysfunction and loss(155). 
441 From the effects on hypoxia on white adipocytes, it was stressed above that as cells are 
442 customarily incubated under hyperoxic conditions (20% O2) we may have obtained a somewhat 
443 distorted view of cellular processes. This may be true for many types of cell, including brown 
444 adipocytes. Finally, one of the implications with the response of white adipocytes to graded 
445 levels of O2 is that cells carefully titrate small changes in the concentration of this critical nutrient 
446 and this results, as with other nutrients, in the continuous modulation of cellular function. 
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826 Legends to Figures
827
828 Fig 1. ‘Engaging’ with nutrition at the Dunn – Friday morning group ‘coffee and cake’. Eating 
829 and drinking in the laboratory is, of course, prohibited now, but was normal in my early years as 
830 a scientist.
831
832 Fig. 2. Schematic of different physiological and pathological conditions in experimental animals 
833 in which energy flux and/or balance are altered where increases, or decreases, in brown adipose 
834 tissue thermogenesis have been demonstrated. Examples of key situations in which brown fat 
835 thermogenesis changes are shown. DIT, diet-induced thermogenesis; PUFA, polyunsaturated 
836 fatty acids; VMH, ventromedial hypothalamus.
837
838 Fig. 3.  The thermogenic activity and capacity of BAT is decreased in lactation. The changes in 
839 mitochondrial GDP binding, the mitochondrial concentration of UCP1 (UCP1 conc) and the 
840 total UCP1 content of the interscapular BAT depot are shown for mice at late lactation (when 
841 milk production is close to maximal) relative to virgin mice (virgin = 1)(39).
842
843 Fig. 4. The secretome of white adipocytes. Fatty acids and other lipids are secreted, together 
844 with a multiplicity of adipokines (proteins); examples of some of the lipids and key adipokines 
845 are shown. The major adipocyte hormones, leptin and adiponectin, are highlighted. angptl4, 
846 angiopoietin-like protein-4; CETP, cholesteryl ester transfer protein; DPP4, dipeptidyl peptidase-
847 4;  IGF, insulin-like growth factor-1;  IL, interleukin; LPL, lipoprotein lipase; MCP-1, monocyte 
848 chemoattractant protein-1; MIC-1, macrophage inhibitory cytokine-1; MIF, macrophage 
849 migration inhibitory factor; MMP, matrix metalloproteinase; NGF, nerve growth factor; PAI-1, 
850 plasminogen activator inhibitor-1; RBP4, retinol binding protein-4; TGFβ, transforming growth 
851 factor-β; TNFα, tumour necrosis factor-α; VEGF, vascular endothelial growth factor; ZAG, 
852 zinc-α2-glycoprotein. 
853
854 Fig. 5. Schematic representation of the central cellular responses to hypoxia in white adipocytes. 
855 The effect of low pO2 on gene expression, glucose uptake and utilisation, and the production of 
856 selected key adipokines is shown. angptl4, angiopoietin-like protein-4; FA, fatty acid; GLUT1, 
857 facilitative glucose transporter 1; HIF-1, hypoxia-inducible factor-1; IL-6, interleukin-6; MCT1, 
858 monocarboxylate transporter-1; MIF, macrophage migration inhibitory factor; MMP, matrix 
859 metalloproteinase; MT-3, metallothionein-3; PAI-1, plasminogen activator inhibitor-1; TF, 
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860 transcription factors (other than HIF-1); VEGF, vascular endothelial growth factor. Modified 
861 from(131).
862
863
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